Higher Caffeine Levels Linked to 35% Lower Risk of Age-Related Eye Disease

Age-related eye diseases like macular degeneration, cataracts, and glaucoma are leading causes of vision loss in older adults, making prevention strategies crucial for healthy aging. While lab studies suggested caffeine might protect eye health, population-based evidence was lacking.

Researchers used Mendelian randomization, a genetic approach that mimics randomized trials, to study whether long-term caffeine exposure protects against eye diseases. They analyzed genetic variants near genes controlling caffeine metabolism to determine causal relationships between plasma caffeine levels and eye disease risk.

The results were striking: higher genetically-predicted caffeine levels reduced dry macular degeneration risk by 35%, wet macular degeneration by 42%, age-related cataracts by 19%, and primary open-angle glaucoma by 25%. Importantly, about half of glaucoma protection came through reduced intraocular pressure, a key glaucoma risk factor.

These findings suggest that regular caffeine consumption throughout life may significantly preserve vision during aging. Unlike previous studies relying on self-reported coffee intake, this research used actual blood caffeine levels, providing more reliable evidence. The genetic approach also eliminates confounding factors that plague observational studies.

However, optimal caffeine doses remain unclear, and individual responses vary based on genetic makeup and tolerance. While promising for longevity and healthy aging, these results need validation in clinical trials before specific recommendations can be made for eye disease prevention.